Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Two-stage, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors After Failure or Intolerability to Standard Treatment

NCT04911907 is registered in ClinicalTrials.gov with Beijing Biostar Pharmaceuticals Co., Ltd. as lead sponsor.

NCT NCT04911907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04911907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Two-stage, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors After Failure or Intolerability to Standard Treatment
Lead sponsor
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 22, 2021
Completion date
May 31, 2025
Enrollment
126 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor